Amphastar Pharmaceuticals AMPH Baqsimi — Other Receivables

Other product segments

Similar metrics at other companies

GYREGNI — Other Receivables

$200K0.0%

BRK.BInsurance And Other — Other Receivables

$5.16B-1.5%

BRK.BRailroad Utilities And Energy — Other Receivables

$632M-7.9%

TPLOil and gas royalties — Accounts receivable and accrued receivables, net

$61.3M+1.0%

KBHHomebuilding — Other

$40.47M+32.2%

BRK.BInsurance And Other — Premiums And Other Receivables Net

$48.64B+2.4%

FAQ

What is Amphastar Pharmaceuticals's baqsimi — other receivables?

Amphastar Pharmaceuticals (AMPH) reported baqsimi — other receivables of $0 in Q2 2026.

What does baqsimi — other receivables mean?

This metric tracks the outstanding amounts owed to the company specifically related to the Baqsimi product line that are categorized outside of standard trade accounts receivable. It captures non-routine financial claims, such as rebates, government incentives, or specific contractual settlements tied to the product's distribution. Monitoring this balance helps investors evaluate the quality of earnings and the efficiency of cash collection processes for this specific segment.